Pinnacle Associates’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-510
| Closed | -$8.84K | – | 815 |
|
|
2024
Q1 | $8.84K | Sell |
510
-42
| -8% | -$728 | ﹤0.01% | 832 |
|
|
2023
Q4 | $7.07K | Sell |
552
-14,863
| -96% | -$190K | ﹤0.01% | 816 |
|
|
2023
Q3 | $570K | Sell |
15,415
-409
| -3% | -$15.1K | 0.01% | 542 |
|
|
2023
Q2 | $637K | Sell |
15,824
-149
| -0.9% | -$6K | 0.01% | 539 |
|
|
2023
Q1 | $1.16M | Buy |
15,973
+245
| +2% | +$17.8K | 0.02% | 388 |
|
|
2022
Q4 | $1.29M | Sell |
15,728
-209
| -1% | -$17.1K | 0.03% | 363 |
|
|
2022
Q3 | $1.51M | Sell |
15,937
-1,211
| -7% | -$114K | 0.03% | 327 |
|
|
2022
Q2 | $3.34M | Sell |
17,148
-43
| -0.3% | -$8.38K | 0.07% | 244 |
|
|
2022
Q1 | $3.99M | Sell |
17,191
-797
| -4% | -$185K | 0.07% | 251 |
|
|
2021
Q4 | $7.09M | Sell |
17,988
-85
| -0.5% | -$33.5K | 0.12% | 185 |
|
|
2021
Q3 | $8.09M | Sell |
18,073
-605
| -3% | -$271K | 0.15% | 163 |
|
|
2021
Q2 | $7.26M | Buy |
18,678
+274
| +1% | +$107K | 0.13% | 169 |
|
|
2021
Q1 | $6.61M | Sell |
18,404
-1,798
| -9% | -$645K | 0.13% | 177 |
|
|
2020
Q4 | $9.91M | Sell |
20,202
-1,421
| -7% | -$697K | 0.2% | 129 |
|
|
2020
Q3 | $7.01M | Sell |
21,623
-454
| -2% | -$147K | 0.17% | 147 |
|
|
2020
Q2 | $8.04M | Buy |
22,077
+5,038
| +30% | +$1.84M | 0.2% | 129 |
|
|
2020
Q1 | $3.63M | Buy |
17,039
+4,078
| +31% | +$868K | 0.11% | 193 |
|
|
2019
Q4 | $5.34M | Buy |
+12,961
| New | +$5.34M | 0.12% | 198 |
|